These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 11962654)
21. [Metabolism of 14C-labeled urea in conventional and bacteria-free guinea pigs]. Juhr NC; Franke J Z Versuchstierkd; 1990; 33(3):123-7. PubMed ID: 2144936 [TBL] [Abstract][Full Text] [Related]
22. Excretion and tissue disposition of dichloroacetonitrile in rats and mice. Roby MR; Carle S; Pereira MA; Carter DE Environ Health Perspect; 1986 Nov; 69():215-20. PubMed ID: 3816725 [TBL] [Abstract][Full Text] [Related]
23. Effect of aspirin on fate of 14C-acetaminophen in guinea pigs. Whitehouse LW; Paul CJ; Thomas BH J Pharm Sci; 1975 May; 64(5):819-21. PubMed ID: 1151653 [TBL] [Abstract][Full Text] [Related]
24. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
25. Fate of [14C]warfarin in guinea-pigs: effect of a concomitant single dose of salicylate. Wong LT; Solomonraj G; Thomas BH J Pharm Pharmacol; 1978 Apr; 30(4):240-3. PubMed ID: 24713 [TBL] [Abstract][Full Text] [Related]
26. Mass balance study of [14C] rabeprazole following oral administration in healthy subjects. Setoyama T; Drijfhout WJ; van de Merbel NC; Humphries TJ; Hasegawa J Int J Clin Pharmacol Ther; 2006 Nov; 44(11):557-65. PubMed ID: 17176622 [TBL] [Abstract][Full Text] [Related]
27. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey. Kanai Y; Nakai Y; Nakajima N; Tanayama S Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449 [TBL] [Abstract][Full Text] [Related]
28. Uptake and distribution of 14C during and following exposure to [14C]methyl isocyanate. Ferguson JS; Kennedy AL; Stock MF; Brown WE; Alarie Y Toxicol Appl Pharmacol; 1988 Jun; 94(1):104-17. PubMed ID: 3376108 [TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals. Dormard Y; Levron JC; Benakis A Arzneimittelforschung; 1975 Feb; 25(2):194-201. PubMed ID: 1173032 [TBL] [Abstract][Full Text] [Related]
30. Effects of dose, strain, and dosing vehicle on methacrylonitrile disposition in rats and identification of a novel-exhaled metabolite. Ghanayem BI; Sanchez IM; Burka LT Drug Metab Dispos; 1992; 20(5):643-52. PubMed ID: 1358567 [TBL] [Abstract][Full Text] [Related]
31. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
32. The disposition of 10-10' oxybisphenoxarsine (OBPA) in rats, rabbits and guinea pigs. Kronenberg J; Hartung R Drug Chem Toxicol; 1981; 4(3):275-81. PubMed ID: 7338206 [TBL] [Abstract][Full Text] [Related]
33. Fate of 14C-terpolymer (methylmethacrylate-14C, 2-hydroxyethylmethacrylate, butylacrylate) nanoparticles after peroral administration to rats. Kukan M; Bezek S; Koprda V; Labský J; Kálal J; Bauerová K; Trnovec T Pharmazie; 1989 May; 44(5):339-40. PubMed ID: 2772015 [TBL] [Abstract][Full Text] [Related]
34. Fate and distribution of 3H-labeled T-2 mycotoxin in guinea pigs. Pace JG; Watts MR; Burrows EP; Dinterman RE; Matson C; Hauer EC; Wannemacher RW Toxicol Appl Pharmacol; 1985 Sep; 80(3):377-85. PubMed ID: 4035695 [TBL] [Abstract][Full Text] [Related]
35. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179 [TBL] [Abstract][Full Text] [Related]
36. The excretion and degradation of chondroitin 4-sulphate administered to guinea pigs as free chondroitin sulphate and as proteoglycan. Revell PA; Muir H Biochem J; 1972 Nov; 130(2):597-606. PubMed ID: 4268885 [TBL] [Abstract][Full Text] [Related]
38. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat. Frantz SW; Ballantyne B; Leung HW Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447 [TBL] [Abstract][Full Text] [Related]
39. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats. Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic analysis and antitumor efficacy of MKT-077, a novel antitumor agent. Tatsuta N; Suzuki N; Mochizuki T; Koya K; Kawakami M; Shishido T; Motoji N; Kuroiwa H; Shigematsu A; Chen LB Cancer Chemother Pharmacol; 1999; 43(4):295-301. PubMed ID: 10071980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]